author-photo

Charles Vogel

Lynn University

11

Papers

192

Citations

Citation Trend

Filter By

Papers (9) Sort By

Journal Conference Others

lighttheneedforresearchdesignedtobetterdefinethecon- textinwhichfishoilmaybenefitpatientswithcoronaryartery disease.

2017
Show All
- Source
- Cite
- Save
Citations (0)
Adjuvant docetaxel, doxorubicin, and cyclophosphamide in node-positive breast cancer: 10-year follow-up of the phase 3 randomised BCIRG 001 trial

2013 Lancet Oncology
Show All
- Source
- Cite
- Save
Citations (162)
Randomized Double-Blind Phase 2 Trial of 3 Doses of TAS-108 in Patients With Advanced or Metastatic Postmenopausal Breast Cancer

2012 Cancer
Show All
- Source
- Cite
- Save
Citations (5)
Reply to R.S. Mehta et al

2009 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Reply to L.C. Panasci

2009 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
BCIRG 001 molecular analysis: Identification of prognostic factors in patients (pts) receiving adjuvant therapy for node- positive (N+) breast cancer (BC)

2007 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (4)
Acupuncture for the management of hot flashes in women with early stage breast cancer treated with tamoxifen or an aromatase inhibitor: A pilot study of efficacy, safety and feasibility

2005 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (4)
Updated results of a multicenter phase II trial of neoadjuvant docetaxel, carboplatin and capecitabine for inflammatory and locally advanced breast cancer (LABC)

2005 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (3)
The role of growth factor support following neutropenic events in early stage breast cancer (BC) patients treated with adjuvant docetaxel, doxorubicin, and cyclophosphamide (TAC): A sub-analysis of BCIRG 001

2004 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (7)